news
CHMP recommends EU approval to update Novartis drug Glivec® label to include three year treatment for GIST patients after surgery
20 January 2012 | By Novartis
Update of the Glivec® (imatinib)* label...
List view / Grid view
Committee for Medicinal Products for Human Use (CHMP)
news
CAPRELSA™ (vandetanib) receives positive CHMP opinion in the European Union for treating advanced medullary thyroid cancer
18 November 2011 | By AstraZeneca
CAPRELSA receives a positive opinion...
news
ALIMTA receives positive opinion from CHMP
26 September 2011 | By Eli Lilly and Company
CHMP has issued a positive opinion for the use of ALIMTA® as continuation maintenance therapy for deadly form of lung cancer...
news
KOMBOGLYZE™ receives positive CHMP opinion in the European Union for the treatment of type 2 diabetes
23 September 2011 | By AstraZeneca
KOMBOGLYZE™ receives a positive opinion from CHMP...
news
Novartis gains positive CHMP opinion for Rasitrio®
23 September 2011 | By Novartis
The CHMP adopted a positive opinion for Rasitrio® for the treatment of high blood pressure...
news
European CHMP adopts positive opinion for Eviplera(R)
23 September 2011 | By Gilead Sciences, Inc.
CHMP, has adopted a positive opinion on the company's Marketing Authorisation Application for the once-daily single-tablet regimen, Eviplera(R)...
news
Positive opinion on the usage of Levemir® (insulin detemir) as add-on therapy to Victoza® (liraglutide) in people with type 2 diabetes
23 September 2011 | By Novo Nordisk
CHMP has adopted a positive opinion on the usage of Novo Nordisk’s basal insulin analogue, Levemir®...
news
Positive opinion on the use of Levemir® (insulin detemir) in children with type 1 diabetes aged two to five years
23 September 2011 | By Novo Nordisk
CHMP has adopted a positive opinion on the extended use of Novo Nordisk’s basal insulin analogue, insulin detemir...
news
GSK and Human Genome Sciences receive positive opinion in Europe from the CHMP for Benlysta® (belimumab)
20 May 2011 | By GlaxoSmithKline
The CHMP has issued a positive opinion, recommending marketing authorisation for Benlysta® (belimumab)...
news
Amgen receives CHMP positive opinion for XGEVA(TM) (Denosumab) in the European Union
20 May 2011 | By Amgen
Amgen announced that the CHMP of the EMA has recommended a positive opinion for the marketing authorization of XGEVA™ (denosumab)...
news
CHMP issues positive opinion for Merck’s VICTRELIS™ (boceprevir)
20 May 2011 | By Merck
Merck announced that the CHMP of the EMA has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS™...
news
European Medicines Agency’s Committee for Medicinal Products for Human Use issues positive opinion on marketing authorisation application for FAMPYRA
20 May 2011 | By Biogen Idec
Biogen Idec announced that FAMPYRA(R) (prolonged-release fampridine tablets) has been granted a positive opinion for conditional approval from the EMA's CHMP...
